All In Biotech

Drug Trial Radar · NCT06126614

Infection Prophylaxis in Total Joint Replacement

Prospective Randomized Evaluation of Emerging Novel Treatments for Infection Prophylaxis in Total Joint Replacement (PREVENT-iT)

Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 21,006 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

21,006

Planned (sponsor's estimate)

Start

May 7, 2024

Primary completion

Nov 2028

Study completion Nov 2028

Sponsor

Lead sponsor
Hamilton Health Sciences CorporationAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
McMaster University; Ontario Clinical Oncology Group (OCOG)
First posted
Nov 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Osteoarthritis (OA) is the most common cause of disability in older adults worldwide affecting 7% of the global population, or more than 500 million people globally. Total joint replacements (TJR) can help bring relief to those with osteoarthritis when other treatment options are no longer helpful. Infection is the main reason hip and knee replacements "fail". Failure leads to repeat surgeries that are often more complicated and less likely to be successful than the first surgery. Reducing the risk of infection is extremely important, antiseptic washes and antibiotics may help us do that. After joint replacement surgery, orthopaedic surgeons wash and clean the surgical wound to lower the risk of infection. The goal of this clinical trial is to determine if the use of antiseptic solutions to wash the surgical site and placing an antibiotic directly into the wound will reduce the number of infections requiring reoperation. Patients having total joint replacements will be randomized (like flipping a coin) to receive 6 possible combinations of washes and / or antibiotics. Participants will be followed for one year after TJR to compare the rate of infection in each group.

Conditions

  • Periprosthetic Joint Infection

Interventions

  • Chlorhexidine GluconateDrug

    0.05% chlorhexidine gluconate solution for irrigation

  • Vancomycin HydrochlorideDrug

    2 grams of topical vancomycin hydrochloride added to the wound

  • Povidone-IodineOther

    0.35% povidone-iodine solution for irrigation

  • SalineOther

    saline for irrigation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The number of reoperations due to infectionTime frame: Within 1 year of total joint replacement

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hamilton Health Sciences - Juravinski Hospital and Cancer Centre

    Hamilton, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.